loadpatents
name:-0.021996021270752
name:-0.013427972793579
name:-0.0091361999511719
Kung; Pei-Pei Patent Filings

Kung; Pei-Pei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kung; Pei-Pei.The latest application filed is for "cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives".

Company Profile
9.18.30
  • Kung; Pei-Pei - San Diego CA
  • Kung; Pei-Pei - Leucadia CA
  • Kung; Pei Pei - Carlsbad CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cycloalkyl and Heterocycloalkyl Benzisoxazole Sulfonamide Derivatives
App 20220251075 - Brodsky; Oleg ;   et al.
2022-08-11
Benzisoxazole Sulfonamide Derivatives
App 20200399258 - Bozikis; Ylva Elisabet Bergman ;   et al.
2020-12-24
Ezh2 Inhibitor Combination Therapies
App 20200268740 - Kraus; Manfred ;   et al.
2020-08-27
Cycloalkyl-linked diheterocycle derivatives
Grant 10,676,471 - Burns , et al.
2020-06-09
Substituted dihydroisoquinolinone compounds
Grant 10,570,121 - Collins , et al. Feb
2020-02-25
Cycloalkyl-Linked Diheterocycle Derivatives
App 20190270737 - Burns; Aaron Craig ;   et al.
2019-09-05
Aryl and heteroaryl fused lactams
Grant 10,246,433 - Edwards , et al.
2019-04-02
Cycloalkyl-Linked Diheterocycle Derivatives
App 20190040055 - Burns; Aaron Craig ;   et al.
2019-02-07
Substituted Dihydroisoquinolinone Compounds
App 20190040047 - Collins; Michael Raymond ;   et al.
2019-02-07
Cycloalkyl-linked diheterocycle derivatives
Grant 10,125,130 - Burns , et al. November 13, 2
2018-11-13
Cycloalkyl-Linked Diheterocycle Derivatives
App 20180148441 - BURNS; Aaron Craig ;   et al.
2018-05-31
Substituted Dihydroisoquinolinone Compounds
App 20170298048 - Collins; Michael Raymond ;   et al.
2017-10-19
Aryl And Heteroaryl Fused Lactams
App 20170233368 - EDWARDS; Martin Paul ;   et al.
2017-08-17
Benzamide And Heterobenzamide Compounds
App 20170152239 - EDWARDS; Martin Paul ;   et al.
2017-06-01
Cycloalkyl-Linked Diheterocycle Derivatives
App 20170050958 - BURNS; Aaron Craig ;   et al.
2017-02-23
Substituted Dihydroisoquinolinone Compounds
App 20160376254 - COLLINS; Michael Raymond ;   et al.
2016-12-29
Substituted dihydroisoquinolinone compounds
Grant 9,481,666 - Kania , et al. November 1, 2
2016-11-01
Substituted Dihydroisoquinolinone Compounds
App 20150361067 - Collins; Michael Raymond ;   et al.
2015-12-17
Benzamide And Heterobenzamide Compounds
App 20150239842 - Edwards; Martin Paul ;   et al.
2015-08-27
Aryl And Heteroaryl Fused Lactams
App 20150175572 - EDWARDS; Martin Paul ;   et al.
2015-06-25
Aryl and heteroaryl fused lactams
Grant 9,040,515 - Edwards , et al. May 26, 2
2015-05-26
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors
App 20140288086 - CUI; Jingrong Jean ;   et al.
2014-09-25
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
Grant 8,785,632 - Cui , et al. July 22, 2
2014-07-22
Aryl And Heteroaryl Fused Lactams
App 20140179667 - EDWARDS; Martin Paul ;   et al.
2014-06-26
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors
App 20120263706 - Cui; Jingrong Jean ;   et al.
2012-10-18
Aminoheteroaryl compounds as protein kinase inhibitors
Grant 8,106,197 - Cui , et al. January 31, 2
2012-01-31
2-amino pyrimidine compounds as potent HSP-90 inhibitors
Grant 8,080,556 - Kung , et al. December 20, 2
2011-12-20
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
Grant 7,858,643 - Cui , et al. December 28, 2
2010-12-28
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors
App 20100324061 - Cui; Jingrong Jean ;   et al.
2010-12-23
2-amino Pyrimidine Compounds
App 20100093696 - Bennett; Michael J. ;   et al.
2010-04-15
2-amino Pyrimidine Compounds As Potent Hsp-90 Inhibitors
App 20100041681 - Kung; Pei-Pei ;   et al.
2010-02-18
Amide Resorcinol Compounds
App 20090215742 - Funk; Lee Andrew ;   et al.
2009-08-27
Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
Grant 7,465,842 - Kung , et al. December 16, 2
2008-12-16
Aminoheteroaryl compounds as protein kinase inhibitors
Grant 7,230,098 - Cui , et al. June 12, 2
2007-06-12
Aminoheteroaryl compounds as protein kinase inhibitors
App 20070072874 - Cui; Jingrong Jean ;   et al.
2007-03-29
Aminoheteroaryl compounds as protein kinase inhibitors
App 20060178374 - Cui; Jingrong Jean ;   et al.
2006-08-10
Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
App 20060128724 - Cui; Jingrong Jean ;   et al.
2006-06-15
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
App 20060046991 - Cui; Jingrong Jean ;   et al.
2006-03-02
Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
App 20060046287 - Kung; Pei-Pei ;   et al.
2006-03-02
Aminoheteroaryl compounds as protein kinase inhibitors
App 20050009840 - Cui, Jingrong Jean ;   et al.
2005-01-13
Combination therapies for treating methylthioadenosine phosphorylase deficient cells
App 20040043959 - Bloom, Laura A. ;   et al.
2004-03-04
Di-nitrogen heterocycle compositions
Grant 6,660,466 - Cook , et al. December 9, 2
2003-12-09
Antibacterial quinazoline compounds
Grant 6,156,758 - Kung , et al. December 5, 2
2000-12-05
Antimicrobial determination of N-(aminoalkyl) and/or N-(Amidoalkyl) dinitrogen heterocyclic compositions
Grant 6,150,129 - Cook , et al. November 21, 2
2000-11-21
Oligomeric compounds having nitrogen-containing linkages
Grant 6,121,433 - Cook , et al. September 19, 2
2000-09-19
Nitrogenous macrocyclic compounds
Grant 6,107,482 - Cook , et al. August 22, 2
2000-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed